ABSTRACT
INTRODUCTION
In modern dentistry, dental implant plays an important role in dental rehabilitation. Its use is widespread and predictable, with survival rates approaching 95%. 1 Its growing use can be attributed to the fact that it offers patients a more sophisticated reconstructive alternative, conserving the tooth structure of the residual dentition and eliminating the need for removable prostheses. 2 Typically, the hallmark of a successful dental implant is when there has been osseointegration at the implant-bone interface. If this fails, then a fibro-osseous integration occurs at the interface resulting in implant instability and ultimately failure (Fig. 1) . Often, placement of an implant requires a significant financial contribution from patients; as such, clinicians should be aware of any potential risk factors that may affect implant osseointegration and failure. Recognizing
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Figs 1A and B: (A) Osseointegration observed at implant-bone interface; and (B) Fibro-osseous integration with formation of connective tissue at implant-bone interface
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conditions that place patients at a higher risk of complications will allow clinicians to refine treatment plans and optimize outcomes. 1 A number of factors have been suggested in the literature to affect implant survival, such as implant location, surgical technique, implant dimensions, and patient-related factors, such as age, BMI, smoking, and DM. However, there still appears to be a wide disparity in the literature relating to the impact of these risk factors on implant failure (Table 1) . As such, this study aims to identify which risk factors are associated with implant failure using Biomet 3i NanoTite Tapered implants in a regional center.
MATERIALS AND METHODS
Data pertaining to patients who received one or more dental implants from 2011 to 2013 in a regional center were retrospectively reviewed. Patients were followed up until the end of 2015. A total of 302 Biomet 3i NanoTite Tapered Certain implants (Warsaw, Indiana, United States) were placed in 177 patients by two surgeons.
The main outcome of interest was implant failure, defined as an implant requiring replacement. Patients were assessed clinically and with intraoral radiography for any form of complication including peri-implantitis and implant mobility, wound dehiscence, infection, persistent bleeding, or lost/broken abutments. A number of variables were investigated including age, gender, DM, smoking, BMI, implant location, and surgical technique.
The data were analyzed using Excel and Statistical Package for the Social Sciences software. Chi-squared test and Pearson coefficient were used to determine the association between variables and failure of implant; p < 0.05 was considered to be statistically significant. The odds ratio and 95% confidence interval (CI) were calculated for variables, which displayed significant associations.
RESULTS
Within the follow-up period, we identified 23 patients who had sustained complications. Fifteen patients failed requiring replacement, giving an overall success rate of 95%. Table 2 summarizes patient information of all 677 677 ** + ** ** -+ -+Statistically significant association with implant failure; -no statistically significant association with implant failure; *Not specified; **Not evaluated failed implants. Three patients presented with wound dehiscence, three with broken/lost abutments, and two with persistent bleeding. The mean follow-up time was 36.3 months (25-51 months). Table 3 summarizes variable factors involved with implant failure.
The mean age of participants was 60.2 ± 15.1 (18-94) years. Nearly 67% of failed implants and 74% of all complications occurred in those who were 60 years of age or greater, with the youngest being 47 years.
The number of implants placed in the maxilla and mandible was comparable, yet 80% of implant failures occurred in the maxilla.
About 67% of failures occurred in single-staged (nonsubmerged) implants. Pearson coefficient demonstrated a weak yet positive correlation between single-stage implants and failure (r = 0.3).
Twenty patients within the sample had been diagnosed with DM. Although there was no relationship with implant failure, all the patients who presented with wound dehiscence had a background of DM. Pearson coefficient demonstrated a positive relationship between the two variables (r = 0.4).
Gender, BMI, implant dimensions, smoking, and surgical operator did not have any impact on implant survival or complications.
DISCUSSION
Implant placement can present a technical challenge for operators. Figure 2 shows the various steps for a single implant placed as a two-stage technique. The overall survival rate for implants within this study was 95% over a period of 3 to 5 years. This is consistent with that of the literature which in recent years has reported a survival rate of 83 to 97%. 7, 8, 11 Although 67% of implant failures occurred in those who were >60 years, this study did not produce a statistically significant result. The literature is divided as to whether advancing age is truly a risk factor for failure. 12, 13 It has been suggested that with advancing age, there are changes in bone and collagen that may result in longer healing periods. An important note to make is that older patients may also have more alveolar bone atrophy, resulting in reduced bone volume and increasing the rate of failure. Ultimately, implants have been placed successfully in the elderly population; 14 however, more research is needed to make tangible and clinically applicable conclusions. Although some studies within the literature suggest that implant site does not have an effect on implant survival, 15 our results found a significant difference in survival when comparing implants placed in the maxilla and mandible. We found that 80% of failures occurred in implants placed in the maxilla (p = 0.02). These results are in line with a number of other studies that produced similar results. 16 We believe that the lower bone density in the upper jaw coupled with low bone volume seen in alveolar atrophy results in the higher failure rate. Despite this, success rates of implants in the maxilla were still at an acceptable 92.3%. The most common length and width of the implants used were with 11.5 mm (8-15) and 4 mm (3.25-6) respectively. A number of studies have identified that an implant length <10 mm was observed as having a success rate as low as 85.3%. 17 With our limited sample size, our results showed a success rate of 75.8% in implants <10 mm (odds ratio of 11.97, 95% CI: 4.00-35.77, p < 0.05). No statistically significant differences were found in relation to implant width. Surgical technique is another important characteristic to consider. We found that single-stage implants (nonsubmerged) had a lower success rate of 85.5% compared with those that were performed as two-stage technique (submerged). In the literature, there continues to be disparity as to whether it makes any impact on implant failure; ultimately, there is a lack of high-quality evidence to be able to make any definitive conclusions. 15 Despite the lack of evidence, we focused single-stage placement on partially dentate patients. Two-stage placement was used in circumstances in which adequate initial stability was not achieved, barriers were required for regeneration, or a removable prosthesis was transmitting excessive forces on the abutment, similar to what is suggested in the literature. 6 The frequency of diabetes is growing, with an estimated 350 million people being affected by 2008. 18 As such, the effect of poorly managed DM and implant failure has been an important topic in the literature. Some authors have found that the presence of diabetes has little impact on implant failure, 19 whereas others would agree that poorly controlled DM has been linked to impaired osseointegration, elevated risk of peri-implantitis and periodontitis. 20 Within our study, we found that the failure rate of those with DM was a lower 85% (odds ratio 3.97, 95% CI: 1.02-15.4, p < 0.05). Furthermore, all three patients who presented with wound dehiscence and impaired healing had a diagnosis of DM. Despite this, there are a number of limitations within this study that we must consider before making definitive conclusions. First, the absence of glycated hemoglobin of patients within the sample prevents us from formulating conclusions related to poor diabetic control and subsequent complications. Furthermore, a larger sample with a longer follow-up period as a follow-up study would help in analyzing the true relationship further.
CONCLUSION
This study has demonstrated that the incidence of implant failure and its complications is affected by a number of important factors that clinicians should consider when assessing patients. A follow-up study with a larger sample size, longer follow-up period, and details of the type of prosthetic rehabilitation would be beneficial in producing more definitive conclusions, which may improve clinical practice. 
